These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21889193)

  • 21. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
    Le T
    Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
    Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and outcomes of uterine and ovarian carcinosarcoma.
    Jonson AL; Bliss RL; Truskinovsky A; Judson P; Argenta P; Carson L; Dusenbery K; Downs LS
    Gynecol Oncol; 2006 Mar; 100(3):561-4. PubMed ID: 16271748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma.
    Chi DS; Mychalczak B; Saigo PE; Rescigno J; Brown CL
    Gynecol Oncol; 1997 Jun; 65(3):493-8. PubMed ID: 9190981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
    Garg G; Kruger M; Christensen C; Deppe G; Toy EP
    Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
    Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
    Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
    Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
    J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
    Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
    Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison between FIGO old and new staging criteria of endometrial carcinoma].
    Jobo T; Ohkawara S; Kuramoto H; Hata H; Shimoda T; Tsunoda S; Tsujii A
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):31-7. PubMed ID: 1997614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Ann Surg Oncol; 2010 Mar; 17(3):861-8. PubMed ID: 19921530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994.
    Cornelison TL; Trimble EL; Kosary CL
    Gynecol Oncol; 1999 Sep; 74(3):350-5. PubMed ID: 10479492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
    Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.